1. Home
  2. GLAD vs BVS Comparison

GLAD vs BVS Comparison

Compare GLAD & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLAD
  • BVS
  • Stock Information
  • Founded
  • GLAD 2001
  • BVS 2011
  • Country
  • GLAD United States
  • BVS United States
  • Employees
  • GLAD N/A
  • BVS N/A
  • Industry
  • GLAD Finance/Investors Services
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • GLAD Finance
  • BVS Health Care
  • Exchange
  • GLAD Nasdaq
  • BVS Nasdaq
  • Market Cap
  • GLAD 644.5M
  • BVS 656.9M
  • IPO Year
  • GLAD N/A
  • BVS 2021
  • Fundamental
  • Price
  • GLAD $24.37
  • BVS $8.20
  • Analyst Decision
  • GLAD Hold
  • BVS Strong Buy
  • Analyst Count
  • GLAD 1
  • BVS 4
  • Target Price
  • GLAD $23.00
  • BVS $15.00
  • AVG Volume (30 Days)
  • GLAD 84.2K
  • BVS 406.5K
  • Earning Date
  • GLAD 04-30-2025
  • BVS 03-11-2025
  • Dividend Yield
  • GLAD 8.80%
  • BVS N/A
  • EPS Growth
  • GLAD 60.05
  • BVS N/A
  • EPS
  • GLAD 4.63
  • BVS N/A
  • Revenue
  • GLAD $95,360,000.00
  • BVS $573,280,000.00
  • Revenue This Year
  • GLAD N/A
  • BVS N/A
  • Revenue Next Year
  • GLAD $10.81
  • BVS $6.09
  • P/E Ratio
  • GLAD $5.84
  • BVS N/A
  • Revenue Growth
  • GLAD 5.53
  • BVS 11.89
  • 52 Week Low
  • GLAD $19.20
  • BVS $3.90
  • 52 Week High
  • GLAD $30.43
  • BVS $14.38
  • Technical
  • Relative Strength Index (RSI)
  • GLAD 28.61
  • BVS 42.95
  • Support Level
  • GLAD $26.70
  • BVS $8.78
  • Resistance Level
  • GLAD $27.82
  • BVS $9.56
  • Average True Range (ATR)
  • GLAD 0.54
  • BVS 0.41
  • MACD
  • GLAD -0.06
  • BVS -0.01
  • Stochastic Oscillator
  • GLAD 14.84
  • BVS 27.49

About GLAD Gladstone Capital Corporation

Gladstone Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objectives are to, achieve and grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness, and make distributions to stockholders that grow over time; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses that can grow over time to permit it to sell its equity investments for capital gains.

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Share on Social Networks: